Industry Reports

Great Point Partners, LLC submitted a letter to the Board of Directors of BioCryst Pharmaceuticals strongly rebuking BCRX's merger with Idera Pharmaceuticals. The letter states "We…
Read More...

Global leader in non-invasive molecular dermatology, DermTech claimed that the late-breaking abstract, "Validation of Noninvasive Gene Expression (PLA) Against High Risk Driver…
Read More...

Cell Medica, asserted the appointment of Kevin S. Boyle, Sr as the Chief Financial Officer, based in Houston, TX.  Kevin S. Boyle ushers on board 20 years of financial and capital…
Read More...

GT Biopharma focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments asserted the appointment of Shawn M.…
Read More...

Influenza Vaccine is one of the best ways known to protect against the flu. However, because of the severity of this season, there have been questions raised about how well this year's…
Read More...

Regentys, a regenerative medicine company, announced it will partner with Cook Biotech Inc., collaborate to develop a novel treatment for ulcerative colitis.Cook Biotech will develop…
Read More...

Astellas Pharma has acquired Universal Cells. Astellas will gain Universal Cells’ proprietary Universal Donor Cell technology to create cell therapy products that do not require Human…
Read More...

ImmunoQure will collaborate with Servier to advance ImmunoQure's therapeutic human Interferon-α autoantibody through preclinical development and into the clinic where Servier will be…
Read More...

Bristol-Myers Squibb Company and Nektar Therapeutics collaborate commercially for Nektar's lead immuno-oncology program, NKTR-214. The companies will jointly develop and…
Read More...

OTTR, the leading provider of organ transplant patient tracking software that improves the quality of patient care via workflow management, has partnered with Hemasoft, an international…
Read More...

FDA has approved a certain Erleada for the treatment of patient inflicted with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with…
Read More...

PharmaMar forays into an exclusive licensing agreement with Seattle Genetics ensuring access to certain PharmaMar proprietary molecules for the development and commercialization of…
Read More...

Ace RNA medicines company, Arcturus Therapeutics asserted the appointment of Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and…
Read More...

Charles River Laboratories International declared that it has ventured into a definitive agreement to obtain MPI Research for $800 million in cash. James C. Foster, Chairman and…
Read More...

Leading provider of nonclinical contract research services and research models, Envigo asserted the appointment of Lynn Lewis to the position of  Senior Vice President, Global Sales.…
Read More...

U.S Food and Drug Administration paved way for the marketing of the Viz.AI Contact application which is a type of clinical decision support software designed to interpret computed…
Read More...

Leading clinical trial technology and specialty services provider, Bracket declared the appointment of Michael Nolte as the company's Chief Executive Officer. Michael Nolte served as…
Read More...

Cytobank and the U.S Food and Drug Administration collaborate to develop machine learning-based methods for characterizing the morphology of multipotent mesenchymal stromal cells…
Read More...

Biopharmaceutical company MOLOGEN AG declared having signed a license deal for the Chinese territory and a global co-development agreement between MOLOGEN and ONCOLOGIE Inc. for its…
Read More...

Teva Pharmaceutical announced the launch of generic version of Syprine (trientine hydrochloride) capsules, 250 mg, in the U.S. Trientine hydrochloride is used in the treatment of…
Read More...